共 30 条
[1]
[Anonymous], Guidance for industry: clinical trial endpoints for the approval of cancer drugs and biologics
[2]
BOBBIOPALLAVICINI E, 1993, J CHEMOTHERAPY, V5, P52
[6]
Burzykowski T., 2005, EVALUATION SURROGATE
[8]
Buyse M, 2000, Biostatistics, V1, P49, DOI 10.1093/biostatistics/1.1.49
[10]
COX DR, 1972, J R STAT SOC B, V34, P187